Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
NCT02805595 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2025-03-28
Summary
This study evaluates the effect of hypertonic saline 23.4% injection in fistulas or sinus tracts in adult patients with hidradenitis suppurativa.
Conditions
Interventions
- DRUG
-
23.4% Hypertonic saline
Saline Injections
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Martina Porter, MD · Beth Israel Deaconess Medical Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2022-11-30
- Completion
- 2022-11-30
Countries
- United States
Study Locations
More Related Trials
-
To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
NCT04476043 ·Status: COMPLETED ·Phase: PHASE2
-
A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa
NCT00395187 ·Status: COMPLETED ·Phase: NA
-
A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa
NCT06201858 ·Status: NOT_YET_RECRUITING
-
Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
NCT05997277 ·Status: TERMINATED ·Phase: PHASE2
-
Hidradenitis Suppurativa Written Action Plan
NCT04230291 ·Status: TERMINATED ·Phase: NA
-
Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
NCT03275870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne
NCT01591304 ·Status: COMPLETED ·Phase: NA
-
A Study With CIT-013 in HS Patients
NCT06993233 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
NCT01838499 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa
NCT04600375 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
NCT04092452 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa
NCT05849922 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients
NCT05470322 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Laser Hair Removal Therapy in HS
NCT05762484 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metformin for the Treatment of Hidradenitis Suppurativa (HS)
NCT04649502 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Hidradenitis Suppurativa on Quality of Life Functions
NCT03288337 ·Status: COMPLETED
-
Nutritional Status and Hidradenitis Suppurativa (Acne Inversa)
NCT03683238 ·Status: COMPLETED
-
Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus
NCT07023952 ·Status: RECRUITING ·Phase: NA
-
15% TOPICAL RESORCINOL FOR HURLEY I-II HIDRADENITIS SUPPURATIVA.
NCT04099212 ·Status: UNKNOWN
-
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
NCT06926192 ·Status: RECRUITING
-
This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
NCT03713619 ·Status: COMPLETED ·Phase: PHASE3
-
Striae Distensae Treatment Using Deep Skin Abrasion
NCT07087405 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa
NCT03929835 ·Status: WITHDRAWN ·Phase: PHASE2
-
Spironolactone for Hidradenitis Suppurativa
NCT04100083 ·Status: WITHDRAWN ·Phase: PHASE4
-
Aviclear for Hidradenitis Suppurativa (HS)
NCT06801795 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA